Itron, Inc. (NASDAQ:ITRI – Free Report) – Zacks Research raised their Q1 2025 earnings estimates for Itron in a report released on Monday, March 17th. Zacks Research analyst R. Department now expects that the scientific and technical instruments company will earn $1.26 per share for the quarter, up from their previous estimate of $1.07. The consensus estimate for Itron’s current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Itron’s Q2 2025 earnings at $1.22 EPS, Q3 2025 earnings at $1.36 EPS, Q2 2026 earnings at $1.47 EPS, Q3 2026 earnings at $1.45 EPS, Q4 2026 earnings at $1.53 EPS and FY2027 earnings at $7.21 EPS.
Several other equities analysts have also recently issued reports on ITRI. Piper Sandler boosted their target price on Itron from $119.00 to $124.00 and gave the company a “neutral” rating in a research note on Thursday, February 27th. Canaccord Genuity Group upped their price objective on shares of Itron from $130.00 to $132.00 and gave the stock a “buy” rating in a report on Wednesday, February 26th. Guggenheim cut their target price on shares of Itron from $135.00 to $133.00 and set a “buy” rating on the stock in a research note on Thursday, February 27th. Oppenheimer boosted their price target on shares of Itron from $124.00 to $131.00 and gave the company an “outperform” rating in a research report on Wednesday, February 26th. Finally, StockNews.com downgraded shares of Itron from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 1st. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, Itron has a consensus rating of “Moderate Buy” and a consensus price target of $127.64.
Itron Trading Down 1.0 %
ITRI opened at $105.49 on Wednesday. Itron has a one year low of $86.45 and a one year high of $124.90. The company has a debt-to-equity ratio of 0.91, a current ratio of 3.36 and a quick ratio of 2.83. The business has a 50 day simple moving average of $103.94 and a two-hundred day simple moving average of $107.54. The firm has a market capitalization of $4.77 billion, a price-to-earnings ratio of 21.62, a PEG ratio of 0.81 and a beta of 1.49.
Insider Buying and Selling
In other news, CAO David Marshall Wright sold 317 shares of Itron stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $92.90, for a total value of $29,449.30. Following the completion of the transaction, the chief accounting officer now owns 8,108 shares of the company’s stock, valued at $753,233.20. The trade was a 3.76 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Mary C. Hemmingsen sold 750 shares of the stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $107.27, for a total transaction of $80,452.50. Following the sale, the director now directly owns 5,630 shares in the company, valued at $603,930.10. This trade represents a 11.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 4,037 shares of company stock worth $385,815 in the last 90 days. Insiders own 1.45% of the company’s stock.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in ITRI. Wealth Enhancement Advisory Services LLC raised its holdings in Itron by 41.5% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 2,955 shares of the scientific and technical instruments company’s stock worth $321,000 after acquiring an additional 867 shares during the last quarter. Menard Financial Group LLC raised its stake in shares of Itron by 12.2% in the fourth quarter. Menard Financial Group LLC now owns 5,684 shares of the scientific and technical instruments company’s stock worth $617,000 after purchasing an additional 619 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of Itron during the fourth quarter valued at $14,563,000. Virtue Capital Management LLC boosted its position in shares of Itron by 5.4% during the fourth quarter. Virtue Capital Management LLC now owns 8,249 shares of the scientific and technical instruments company’s stock valued at $896,000 after buying an additional 419 shares during the last quarter. Finally, GTS Securities LLC bought a new stake in Itron in the 4th quarter worth about $288,000. Institutional investors own 96.19% of the company’s stock.
Itron Company Profile
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Read More
- Five stocks we like better than Itron
- How to invest in marijuana stocks in 7 steps
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- 3 Must-Own Stocks to Build Wealth This Decade
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.